Skip to content

Biosan Biyoteknoloji San. ve Dış Tic. A.Ş.

Active in EUDAMED

Türkiyefrom SRN EUDAMED SRN TR-MF-000038203

Devices
136
Registrations
EUDAMED

What Biosan Biyoteknoloji San. ve Dış Tic. A.Ş. makes

Biosan Biyoteknoloji produces hyaluronic acid-based pre-filled injection devices, including intra-articular and soft tissue treatments such as Triomax™, Hydense™, HyaRelief™, and GOLDVISC™. Their portfolio also includes joint repair and regenerative products like CHONDROCROSS, CHONDROPLUS™, and NANOFlex™, as well as wound healing and tissue regeneration solutions such as Recovertendo L™ and VONALF™. Additional offerings include bone and cartilage regeneration products like NEXOL™ BIO-NEXOL and NEXOL™ BONEXOL, alongside balance and mobility aids such as SINOBALANCE™.

All listed devices fall under Class III regulatory classification and are registered in the euDaMed database. The company is based in Turkey.

AI-generated from registry data, 3 Oct 2026. Not verified by deviCERTS or the manufacturer.

Catalogue136

Newest first, rows 51-100 of 136

Search and filter all 136 devices
Skip device list
  • OrthOne+1® Ref BHA253ORT

    Active Regimes: CE MDD Registry: EUDAMED Class:III
  • Nevacross™ Ref BHA253ARN

    Active Regimes: CE MDD Registry: EUDAMED Class:III
  • Diemflex™ Plus Ref BHA202INT

    Active Regimes: CE MDD Registry: EUDAMED Class:III
  • Viscocell™ Ref BHA202VCL

    Active Regimes: CE MDD Registry: EUDAMED Class:III
  • Chondrocross Ref BHA303THA

    Active Regimes: CE MDD Registry: EUDAMED Class:III
  • HyaRelief™ Ref BHA202RLF

    Active Regimes: CE MDD Registry: EUDAMED Class:III
  • Ultravisc™ Ref BHA253HYY

    Active Regimes: CE MDD Registry: EUDAMED Class:III
  • Orthocross™ Ref BHA253BLK

    Active Regimes: CE MDD Registry: EUDAMED Class:III
  • Hyapure™ Ref BHA202HYP

    Active Regimes: CE MDD Registry: EUDAMED Class:III
  • HyaRelief™ Ref BHA151RLF

    Active Regimes: CE MDD Registry: EUDAMED Class:III
  • Viscogel™ Cross Ref BHA303MRT

    Active Regimes: CE MDD Registry: EUDAMED Class:III
  • Primevisc™ Ref BHA2425HGH

    Active Regimes: CE MDD Registry: EUDAMED Class:III
  • Ultravisc™ Ref BHA152UVC

    Active Regimes: CE MDD Registry: EUDAMED Class:III
  • Jocross™ Ref BHA253BLM

    Active Regimes: CE MDD Registry: EUDAMED Class:III
  • Chondhya™ Ref BHA202CHN

    Active Regimes: CE MDD Registry: EUDAMED Class:III
  • Prolycine™ Ref BHA202PRO

    Active Regimes: CE MDD Registry: EUDAMED Class:III
  • Hyasource™ Ref BHA2425HYS

    Active Regimes: CE MDD Registry: EUDAMED Class:III
  • Hyagel™ Ref BHA253HYG

    Active Regimes: CE MDD Registry: EUDAMED Class:III
  • Diemflex™ Plus Ref BHA102INT

    Active Regimes: CE MDD Registry: EUDAMED Class:III
  • Tendogenial™ Pro Ref BHA102BBS

    Active Regimes: CE MDD Registry: EUDAMED Class:III
  • Visco-Z™ Ref BHA253VIS

    Active Regimes: CE MDD Registry: EUDAMED Class:III
  • Biovisc™ Prime Ref BHA303BVC

    Active Regimes: CE MDD Registry: EUDAMED Class:III
  • KneeGen™ Ref BHA253HYF

    Active Regimes: CE MDD Registry: EUDAMED Class:III
  • Hyavisc™ Ref BHA202HYV

    Active Regimes: CE MDD Registry: EUDAMED Class:III
  • Hyapure™ Ref BHA303HYP

    Active Regimes: CE MDD Registry: EUDAMED Class:III
  • Prolycine™ Ref BHA102PRO

    Active Regimes: CE MDD Registry: EUDAMED Class:III
  • Biovisc™ Forte Ref BHA152BVC

    Active Regimes: CE MDD Registry: EUDAMED Class:III
  • Hial™ Max 100 Ref BHA100C09

    Active Regimes: CE MDD Registry: EUDAMED Class:III
  • Viscocell™ Ref BHA2425VCL

    Active Regimes: CE MDD Registry: EUDAMED Class:III
  • Alsegovisc™ Ref BHA253JNT

    Active Regimes: CE MDD Registry: EUDAMED Class:III
  • Enflex™ Ref BHA202HLX

    Active Regimes: CE MDD Registry: EUDAMED Class:III
  • Prolycine™ Ref BHA2425PRO

    Active Regimes: CE MDD Registry: EUDAMED Class:III
  • OrthOne+1® Ref BHA202ORT

    Active Regimes: CE MDD Registry: EUDAMED Class:III
  • Hyasource™ Ref BHA202HYS

    Active Regimes: CE MDD Registry: EUDAMED Class:III
  • Arthrowell™ Ref BHA202ART

    Active Regimes: CE MDD Registry: EUDAMED Class:III
  • Hyalartin™ Ref BHA162HCL

    Active Regimes: CE MDD Registry: EUDAMED Class:III
  • Ultravisc™ Ref BHA102UVC

    Active Regimes: CE MDD Registry: EUDAMED Class:III
  • Vi̇sco-Z™ Ref BHA2425VIS

    Active Regimes: CE MDD Registry: EUDAMED Class:III
  • Hyapure™ Ref BHA2425HYP

    Active Regimes: CE MDD Registry: EUDAMED Class:III
  • Hyavisc™ Ref BHA303HYV

    Active Regimes: CE MDD Registry: EUDAMED Class:III
  • Hyavisc™ Ref BHA253HYV

    Active Regimes: CE MDD Registry: EUDAMED Class:III
  • OrtoTendon HA Ref BHA102ALT

    Active Regimes: CE MDD Registry: EUDAMED Class:III
  • Rejenart™ Ref BHA303HSA

    Active Regimes: CE MDD Registry: EUDAMED Class:III
  • Poyartro™ Balance Ref BHA253HLA

    Active Regimes: CE MDD Registry: EUDAMED Class:III
  • Biovisc™ Ultra Ref BHA253BVC

    Active Regimes: CE MDD Registry: EUDAMED Class:III
  • Viscocell™ Ref BHA242VCL

    Active Regimes: CE MDD Registry: EUDAMED Class:III
  • Ultravisc™ Ref BHA303HYY

    Active Regimes: CE MDD Registry: EUDAMED Class:III
  • Viscocell™ Ref BHA152VCL

    Active Regimes: CE MDD Registry: EUDAMED Class:III
  • Goldvisc™ Ref BHA253BIO

    Active Regimes: CE MDD Registry: EUDAMED Class:III
  • CartiGel™ Ref BHA202CAR

    Active Regimes: CE MDD Registry: EUDAMED Class:III

Rows 51-100 of 136

Showing 51-100 of 136

Company details

EUDAMED SRN
TR-MF-000038203
EU VAT number
1760409610
EUDAMED status
Active
EUDAMED registered name
Biosan Biyoteknoloji San. ve Dış Tic. A.Ş.
Registered address
Barış Mah. Koşuyolu Cad. Dış Kapı:26 İç Kapı:30-31 Gebze, 41400, Kocaeli, Türkiye
Phone
+90 262 503 25 10
PRRC contact
Aliye Aslı Esenpınar(public in EUDAMED)

From the company website

Read 18 Oct 2026

Biosan Biotechnology started its R&D studies in Tubitak Marmara Teknokent "R&D and Innovation Center" in 2015 and attaches great importance to its work in the field of medical devices. As Biosan Biotechnology, we continue our product development studies as well as the production of medical devices offered with Hyaluronic Acid-based Pre-filled Injection, whose R&D studies were completed in 2021.

From the manufacturer's own website. Source